CECCHI, FRANCO
CECCHI, FRANCO
AREA CRITICA MEDICO CHIRURGICA (attivo dal 01/01/2000 al 31/12/2012)
'End-stage' hypertrophic cardiomyopathy: from mystery to model
2007 M.H.Yacoub ; I Olivotto ; F Cecchi
A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy
2006 Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; F Cecchi
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening
2021 Maurizi N.; Baldi M.; Castelletti S.; Lisi C.; Galli M.; Bianchi S.; Panzera F.; Fumagalli C.; Mochi N.; Parati G.; Olivotto I.; Cecchi F.
An expert consensus document on the management of cardiovascular manifestations of Fabry disease
2020 Linhart A.; Germain D.P.; Olivotto I.; Akhtar M.M.; Anastasakis A.; Hughes D.; Namdar M.; Pieroni M.; Hagege A.; Cecchi F.; Gimeno J.R.; Limongelli G.; Elliott P.
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy
2015 Gajendrarao P.; Krishnamoorthy N.; Selvaraj S.; Girolami F.; Cecchi F.; Olivotto I.; Yacoub M.
ARRHYTHMIAS ASSOCIATED WITH HYPERTROPHIC CARDIOMYOPATHY
2005 BJ. MARON ; I. OLIVOTTO; F. CECCHI
Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy
2008 Olivotto I; Maron MS; Autore C; Lesser JR; Rega L; Casolo G; De Santis M; Quarta G; Nistri S; F Cecchi ; Salton CJ; Udelson JE; Manning WJ; Maron BJ
Beta-Blockers for Prevention of Exercise-induced Left Ventricular Outflow Obstruction in Patients with Hypertrophic Cardiomyopathy
2010 Stefano Nistri; Iacopo Olivotto; Martin S. Maron; Cecilia Ferrantini; Raffele Coppini; Camilla Grifoni; Katia Baldini; Aurelio Sgalambro; Franco Cecchi; Barry J. Maron
CARDIOMIOPATIA IPERTROFICA
2008 F. Cecchi; I. Olivotto; S. Nistri
Cardiomiopatie, Miocarditi e Pericarditi
2017 Franco Cecchi, Iacopo Olivotto, Domenico corrado, antonio pelliccia, andrea di lenarda, gianfranco sinagra, massimo lombardi
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®)
2017 Maurizi N.; Faragli A.; Imberti J.; Briante N.; Targetti M.; Baldini K.; Sall A.; Cisse A.; Berzolari F.G.; Borrelli P.; Avvantaggiato F.; Perlini S.; Marchionni N.; Cecchi F.; Parigi G.; Olivotto I.
CHARACTERISTICS OF MYOCARDIAL HYPERTROPHY IN FRIEDREICH'S ATAXIA. CLINICO-INSTRUMENTAL STUDY IN 10 PATIENTS AND REVIEW OF THE LITERATURE
1987 F. CECCHI; FAVILLI S; SQUILLANTINI G; ZUPPIROLI A; MASINI M; DE SIMONE L; DE SCISCIOLO G; DOLARA A
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.
2008 Elliott P; Andersson B; Arbustini E; Bilinska Z; F Cecchi ; Charron P; Dubourg O; Kühl U; Maisch B; McKenna WJ; Monserrat L; Pankuweit S; Rapezzi C; Seferovic P; Tavazzi L; Keren A
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy
2019 Maurizi N.; Michels M.; Rowin E.J.; Semsarian C.; Girolami F.; Tomberli B.; Cecchi F.; Maron M.S.; Olivotto I.; Maron B.J.
CLINICAL COURSE OF HYPERTROPHIC CARDIOMYOPATHY IN A NON SELECTED POPULATION. EXPERIENCE OF THE ITALIAN MULTICENTER CARDIOMYOPATHY STUDY
1997 F. CECCHI; OLIVOTTO I; LAZZERONI E; CHIRIATTI G; SACHERO A; BERETTA L; GIAGNONI E; RENOSTO G; MONTEREGGI A; BALDASSARRE S; CASTELLI G; CIACCHERI M
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
2010 Girolami F.; Ho C.Y.; Semsarian C.; Baldi M.; Will M.L.; Baldini K.; Torricelli F.; Yeates L.; Cecchi F.; Ackerman M.J.; Olivotto I.
CLINICAL PROFILE OF STROKE IN 900 PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
2002 MARON BJ; OLIVOTTO I; BELLONE P; CONTE MR; F. CECCHI; FLYGENRING BP; CASEY SA; GOHMAN TE; BONGIOANNI S; SPIRITO P
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy
2015 Pasqualucci D.; Fornaro A.; Castelli G.; Rossi A.; Arretini A.; Chiriatti C.; Targetti M.; Girolami F.; Corda M.; Orru P.; Matta G.; Stefano P.; Cecchi F.; Porcu M.; Olivotto I.
CLINICAL UTILITY AND SAFETY OF EXERCISE TESTING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
1999 I. OLIVOTTO ;A. MONTEREGGI;F. MAZZUOLI ; F. CECCHI
Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanism and clinical consequences
2004 I. OLIVOTTO; F. CECCHI; PG. CAMICI
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 'End-stage' hypertrophic cardiomyopathy: from mystery to model | 2007 | M.H.Yacoub ; I Olivotto ; F Cecchi | |
| A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy | 2006 | Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; F Cecchi | |
| Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening | 2021 | Maurizi N.; Baldi M.; Castelletti S.; Lisi C.; Galli M.; Bianchi S.; Panzera F.; Fumagalli C.; Mochi N.; Parati G.; Olivotto I.; Cecchi F. | |
| An expert consensus document on the management of cardiovascular manifestations of Fabry disease | 2020 | Linhart A.; Germain D.P.; Olivotto I.; Akhtar M.M.; Anastasakis A.; Hughes D.; Namdar M.; Pieroni M.; Hagege A.; Cecchi F.; Gimeno J.R.; Limongelli G.; Elliott P. | |
| An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy | 2015 | Gajendrarao P.; Krishnamoorthy N.; Selvaraj S.; Girolami F.; Cecchi F.; Olivotto I.; Yacoub M. | |
| ARRHYTHMIAS ASSOCIATED WITH HYPERTROPHIC CARDIOMYOPATHY | 2005 | BJ. MARON ; I. OLIVOTTO; F. CECCHI | |
| Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy | 2008 | Olivotto I; Maron MS; Autore C; Lesser JR; Rega L; Casolo G; De Santis M; Quarta G; Nistri S; F Cecchi ; Salton CJ; Udelson JE; Manning WJ; Maron BJ | |
| Beta-Blockers for Prevention of Exercise-induced Left Ventricular Outflow Obstruction in Patients with Hypertrophic Cardiomyopathy | 2010 | Stefano Nistri; Iacopo Olivotto; Martin S. Maron; Cecilia Ferrantini; Raffele Coppini; Camilla Grifoni; Katia Baldini; Aurelio Sgalambro; Franco Cecchi; Barry J. Maron | |
| CARDIOMIOPATIA IPERTROFICA | 2008 | F. Cecchi; I. Olivotto; S. Nistri | |
| Cardiomiopatie, Miocarditi e Pericarditi | 2017 | Franco Cecchi, Iacopo Olivotto, Domenico corrado, antonio pelliccia, andrea di lenarda, gianfranco sinagra, massimo lombardi | |
| Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) | 2017 | Maurizi N.; Faragli A.; Imberti J.; Briante N.; Targetti M.; Baldini K.; Sall A.; Cisse A.; Berzolari F.G.; Borrelli P.; Avvantaggiato F.; Perlini S.; Marchionni N.; Cecchi F.; Parigi G.; Olivotto I. | |
| CHARACTERISTICS OF MYOCARDIAL HYPERTROPHY IN FRIEDREICH'S ATAXIA. CLINICO-INSTRUMENTAL STUDY IN 10 PATIENTS AND REVIEW OF THE LITERATURE | 1987 | F. CECCHI; FAVILLI S; SQUILLANTINI G; ZUPPIROLI A; MASINI M; DE SIMONE L; DE SCISCIOLO G; DOLARA A | |
| Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. | 2008 | Elliott P; Andersson B; Arbustini E; Bilinska Z; F Cecchi ; Charron P; Dubourg O; Kühl U; Maisch B; McKenna WJ; Monserrat L; Pankuweit S; Rapezzi C; Seferovic P; Tavazzi L; Keren A | |
| Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy | 2019 | Maurizi N.; Michels M.; Rowin E.J.; Semsarian C.; Girolami F.; Tomberli B.; Cecchi F.; Maron M.S.; Olivotto I.; Maron B.J. | |
| CLINICAL COURSE OF HYPERTROPHIC CARDIOMYOPATHY IN A NON SELECTED POPULATION. EXPERIENCE OF THE ITALIAN MULTICENTER CARDIOMYOPATHY STUDY | 1997 | F. CECCHI; OLIVOTTO I; LAZZERONI E; CHIRIATTI G; SACHERO A; BERETTA L; GIAGNONI E; RENOSTO G; MONTEREGGI A; BALDASSARRE S; CASTELLI G; CIACCHERI M | |
| Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations | 2010 | Girolami F.; Ho C.Y.; Semsarian C.; Baldi M.; Will M.L.; Baldini K.; Torricelli F.; Yeates L.; Cecchi F.; Ackerman M.J.; Olivotto I. | |
| CLINICAL PROFILE OF STROKE IN 900 PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY | 2002 | MARON BJ; OLIVOTTO I; BELLONE P; CONTE MR; F. CECCHI; FLYGENRING BP; CASEY SA; GOHMAN TE; BONGIOANNI S; SPIRITO P | |
| Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy | 2015 | Pasqualucci D.; Fornaro A.; Castelli G.; Rossi A.; Arretini A.; Chiriatti C.; Targetti M.; Girolami F.; Corda M.; Orru P.; Matta G.; Stefano P.; Cecchi F.; Porcu M.; Olivotto I. | |
| CLINICAL UTILITY AND SAFETY OF EXERCISE TESTING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY | 1999 | I. OLIVOTTO ;A. MONTEREGGI;F. MAZZUOLI ; F. CECCHI | |
| Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanism and clinical consequences | 2004 | I. OLIVOTTO; F. CECCHI; PG. CAMICI |